Fresh Tracks Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.frtx.com
Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis
Phase 1
Terminated
- Conditions
- Atopic Dermatitis Eczema
- Interventions
- Drug: FRTX-02 CapsuleDrug: Placebo
- First Posted Date
- 2022-05-19
- Last Posted Date
- 2023-08-24
- Lead Sponsor
- Fresh Tracks Therapeutics, Inc.
- Target Recruit Count
- 89
- Registration Number
- NCT05382819
- Locations
- 🇨🇦
Syneos Health Quebec, Montréal, Quebec, Canada
Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis
Phase 1
Completed
- Conditions
- Contact Dermatitis
- Interventions
- First Posted Date
- 2017-03-24
- Last Posted Date
- 2017-07-17
- Lead Sponsor
- Fresh Tracks Therapeutics, Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT03089775
- Locations
- 🇨🇦
Innovaderm Research Inc., Montreal, Quebec, Canada
A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects
- First Posted Date
- 2015-10-29
- Last Posted Date
- 2023-01-19
- Lead Sponsor
- Fresh Tracks Therapeutics, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02590289
- Locations
- 🇺🇸
Celerion Inc., Lincoln, Nebraska, United States
News
No news found